The role of MT2 and anti‐bcl‐2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B‐lymphocytes with germinal center formation
Authors:
- 1 August 1996
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 23 (4) , 319-322
Abstract
MT2/CD45RA and anti‐bcl‐2 protein (Bcl‐2) monoclonal antibodies are useful markers in distinguishing follicular lymphomas from reactive follicular hyperplasia of the lymph nodes. We examined biopsy specimens from 11 patients with primary cutaneous B‐cell follicle center lymphomas, 10 patients with cutaneous pseudolymphomas with germinal centers, and 6 patients with inflammatory infiltrates with germinal centers in non‐lymphoid cutaneous tumors (3 basal cell carcinomas, 2 malignant melanomas, and 1 solar keratosis), in order to evaluate the utility of MT2 and anti‐Bcl‐2 antibodies in differentiating benign from malignant germinal center cell proliferations in the skin. Immunohistochemical evaluation of MT2 and Bcl‐2 was focused exclusively on the reactivity of germinal center cells. Specific membranous MT2 positivity was found in 2/11 cutaneous follicle center lymphomas; a diffuse, non‐specific staining pattern was identified in 3/11 follicle center lymphomas and in 1/6 inflammatory infiltrates in non‐lymphoid tumors. A negative MT2 reaction was observed in 6/11 follicle center cell lymphomas, in all cases of pseudolymphomas and in 5/6 inflammatory infiltrates in non‐lymphoid tumors. Bcl‐2 positivity was detected only in 1/11 follicle center lymphomas. Germinal center cells in all other cases were Bcl‐2 negative. Our results suggest that MT2 and anti‐Bcl‐2 antibodies are only of limited value in differentiating primary cutaneous follicle center lymphomas from cutaneous pseudolymphomas with germinal centers.Keywords
This publication has 13 references indexed in Scilit:
- Immunoreactivity for bcl‐2 protein in cutaneous lymphomas and lymphoid hyperplasias*Journal of Cutaneous Pathology, 1995
- bcl-2 Protein Expression and Correlation with the Interchromosomal 14;18 Translocation in Cutaneous Lymphomas and PseudolymphomasJournal of Investigative Dermatology, 1994
- Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reactionJournal of Cutaneous Pathology, 1992
- Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas a comparative clinicopathologic study of 57 patientsCancer, 1990
- Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: A comparative studyJournal of the American Academy of Dermatology, 1990
- Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal TranslocationNew England Journal of Medicine, 1988
- Monoclonal antibodies reactive with normal and neoplastic T cells in paraffin sectionsHuman Pathology, 1988
- UPDATED KIEL CLASSIFICATION FOR LYMPHOMASThe Lancet, 1988
- Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant LymphomasNew England Journal of Medicine, 1987
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982